Vanda eyes first FDA-approved delayed sleep-wake disorder drug0ShareHealthVanda eyes first FDA-approved delayed sleep-wake disorder drug10 sources·Updated Oct 1, 2026·1 min read0Photo: Artem Podrez / Wikimedia Commons (Pexels)SponsoredSponsoredIn this story:🏷️VandaTagWhere do you stand?VandaSupportOpposeMore on this storyBack to NewsPoliticsTrump Forms Committee to Probe Fed’s CookTrump ordered a committee on Friday to investigate Fed Governor Lisa Cook over mortgage allegations, with an in-person hearing set for Nov. 5, 2026.87 sourcesFinanceReports Show Short Positions Shifting Across MarketsNasdaq-reported short interest across its listed securities rose to 23.09 billion shares at Sept. 30, up from 22.52 billion two weeks earlier, while days to cover fell. Separate reports noted a sharp percentage increase in short interest for the Harbor Long-Short Equity ETF and growing leveraged crypto short bets; Sweden’s largest disclosed stock shorts also shifted, with Electrolux posting the biggest increase and AAK the biggest decrease.